Work With Us
Contact Us
Work With Us
Contact Us
Search
Home
About Us
Our Mission and Vision
Meet the Team
Senior Management
Board of Directors
Scientific Advisory Board
Investors
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Clinical Trials
What’s New
Press Releases
Publications
Upcoming Events
In the News
Home
About Us
Our Mission and Vision
Meet the Team
Senior Management
Board of Directors
Scientific Advisory Board
Investors
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Clinical Trials
What’s New
Press Releases
Publications
Upcoming Events
In the News
In the News
GEN: Expanding the Druggable Proteome with Tech Advances
March 9, 2026
In the News
Targeted Oncology: New Targets Emerge for Aggressive Small Cell Lung Cancer
September 16, 2025
In the News
Nature: Research Briefing: Anticancer compounds that exploit a compromised checkpoint in the cell cycle
August 20, 2025
In the News
San Francisco Business Times: Revving up macrocycles, Circle Pharma rides into new, larger space
May 26, 2025
In the News
Scrip: Boehringer Sees A Winner In Circle Pharma’s First-In-Class Cancer Approach
October 9, 2024
In the News
FierceBiotech: Boehringer unveils $607M deal to land Circle’s preclinical cancer program
October 9, 2024
In the News
LOAD MORE
Sign up to stay informed
SUBSCRIBE
Subscribe to our News Alerts
By checking the box and pressing the subscribe button , I acknowledge and accept Circle Pharma’s
Privacy Policy
and
Terms of Service.
Subscribe
